17
Participants
Start Date
April 30, 2014
Primary Completion Date
August 31, 2014
Study Completion Date
August 31, 2014
Topical Tranexamic Acid 5% with bacitracin
Selected participants received a fixed amount of tranexamic acid 5 %and bacitracin applied with compression up to 3 times (13 minutes total) per hemodialysis fistula needle site.
Topical Tranexamic Acid 25% with bacitracin
Selected participants received a fixed amount of tranexamic acid 25%and bacitracin applied with compression up to 3 times (13 minutes total) per hemodialysis fistula needle site.
Fresenius Medical Care - Kearny Mesa, San Diego
California Insitute of Renal Research, San Diego
Fresenious Medical Care - Rancho, San Diego
Lead Sponsor
Collaborators (1)
Imprimis Pharmaceuticals, Inc.
INDUSTRY
California Institute of Renal Research
OTHER